Effective Monday, April 12, 2021, ProMedica Pathology Laboratories (PPL) is pleased to announce an additional serological test offering for SARS-CoV-2 Antibodies, specific to the spike (S) protein using the Roche Electrochemiluminescent Immunoassay (ECLIA). Please refer to the attached pdf for database updates and changes..